Main Menu
Menu

Council for Innovation Promotion

Publish Date
Resources
Public Comments
C4IP Comments RE: Experimental Use Exception Request for Comments (PTO-C-2024-0023)
Op-Eds
Claims That Scientists are Underreporting Federal Support on Patents Don’t Pass the Smell Test
IPWatchdog
Resources
Letters
C4IP Letter to Senate HELP Committee on the Hearing on the Medication Affordability and Patent Integrity Act

Dear Chairman Sanders and Ranking Member Cassidy: In advance of the Committee’s September 26, 2024, Executive Session, I am writing to express...

Resources
Letters
C4IP Letter to Senate Judiciary Committee on PERA

Dear Chairman Durbin and Ranking Member Graham: In light of the Committee’s upcoming markup of S. 2140, the Patent Eligibility Restoration Act...

BlogFact Checks
Fact Check: The Medication Affordability and Patent Integrity Act Would Unnecessarily Overhaul a Well-Functioning Patent System

The Medication Affordability and Patent Integrity Act, introduced by Senators Maggie Hassan (D-NH) and Mike Braun (R-IN), would require life sciences innovators...

Resources
Letters
C4IP Letter to Senate Judiciary Committee on PERA, PREVAIL Act, and IDEA

Dear Chairman Durbin and Ranking Member Graham, In advance of your September 19, 2024, Executive Business Meeting, I am writing to express...

Resources
Letters
C4IP Letter to Senate Judiciary Committee on IDEA Act

Dear Chairman Durbin and Ranking Member Graham: I write on behalf of the Council for Innovation Promotion (C4IP) to voice our organization’s...

Resources
Public Comments
C4IP Comments RE: 2024 Guidance Update on Patent Subject Matter Eligibility, Including on Artificial Intelligence (PTO-P-2024-0026)
Blog
Inventor Spotlight: Frederic Eugene Ives

This month, C4IP is recognizing Frederic Eugene Ives, whose prolific inventions pioneered several technological leaps in photography. Ives was born in 1856...

Press Releases
Council for Innovation Promotion Applauds House Introduction of IDEA Act

WASHINGTON (September 13, 2024) — The Council for Innovation Promotion (C4IP) celebrates the introduction of the Inventor Diversity for Economic Advancement (IDEA)...

Resources
Reports
Overview of the USPTO Drug Exclusivity Report
Press Releases
Council for Innovation Promotion Statement on House Introduction of the Nurture Originals, Foster Art, and Keep Entertainment Safe (NO FAKES) Act of 2024

WASHINGTON (September 12, 2024) — Today, Reps. María Elvira Salazar (R-FL), Madeleine Dean (D-PA), Nathaniel Moran (R-TX), Adam Schiff (D-CA), Rob Wittman...

Resources:

Resources:

C4IP Comments RE: Experimental Use Exception Request for Comments (PTO-C-2024-0023),

09/26/2024
Op-Eds:

Op-Eds:

Claims That Scientists are Underreporting Federal Support on Patents Don’t Pass the Smell Test,

09/25/2024
Resources:

Resources:

C4IP Letter to Senate HELP Committee on the Hearing on the Medication Affordability and Patent Integrity Act,

09/25/2024
Resources:

Resources:

C4IP Letter to Senate Judiciary Committee on PERA,

09/24/2024
Blog:

Blog, Fact Checks:

Fact Check: The Medication Affordability and Patent Integrity Act Would Unnecessarily Overhaul a Well-Functioning Patent System,

09/23/2024
Resources:

Resources:

C4IP Letter to Senate Judiciary Committee on PERA, PREVAIL Act, and IDEA,

09/18/2024
Resources:

Resources:

C4IP Letter to Senate Judiciary Committee on IDEA Act,

09/17/2024
Resources:

Resources:

C4IP Comments RE: 2024 Guidance Update on Patent Subject Matter Eligibility, Including on Artificial Intelligence (PTO-P-2024-0026),

09/16/2024
Blog:

Blog:

Inventor Spotlight: Frederic Eugene Ives,

09/13/2024
Press Releases:

Press Releases:

Council for Innovation Promotion Applauds House Introduction of IDEA Act,

09/13/2024
Resources:

Resources:

Overview of the USPTO Drug Exclusivity Report,

09/12/2024
Press Releases:

Press Releases:

Council for Innovation Promotion Statement on House Introduction of the Nurture Originals, Foster Art, and Keep Entertainment Safe (NO FAKES) Act of 2024,

09/12/2024
Scroll to Top